LNAI · Lunai Bioworks Inc.

Shares were transferred to RS Group ApS pursuant to a settlement agreement terminating the action entitled RS Group ApS v. GWRS Holdings LLC et al. (Superior Court of Los Angeles County, CA, Case No. 22STCV26335).

Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS).

This option vests in five equal annual installments beginning on December 30, 2025.

This option vests in eight equal quarterly installments beginning on January 6, 2025.

These restricted shares vest in five equal annual installments beginning on December 30, 2025.

This option vests upon the termination of the Consulting Agreement effective November 4, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date.

The option vests in eight equal quarterly installments beginning on January 1, 2025.

The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.

The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant.

The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.

This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.30 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is sole manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.45 to $1.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is sole manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

The Reporting Person is a manager of Weird Science LLC.

The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla.

The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

This option vests upon the termination of the Consulting Agreement effective March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

The Preferred Stock is convertible into common stock on a 1-for-10 basis.

The Preferred Stock is perpetual and has no expiration date.

The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

The option vested on January 22, 2023.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024.

The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

The option vested in three equal installments on February 28, 2019, February 28, 2020 and February 28, 2021.